On Monday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) opened higher 15.60% from the last session, before settling in for the closing price of $31.98. Price fluctuations for TNXP have ranged from $6.76 to $137.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 93.08% at the time writing. With a float of $7.35 million, this company’s outstanding shares have now reached $7.36 million.
The firm has a total of 81 workers. Let’s measure their productivity. In terms of profitability, gross margin is 29.81%, operating margin of -721.51%, and the pretax margin is -1146.27%.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.07%, while institutional ownership is 6.58%. The most recent insider transaction that took place on May 15 ’25, was worth 86,200. In this transaction Chief Executive Officer of this company bought 4,000 shares at a rate of $21.55, taking the stock ownership to the 4,005 shares.
Tonix Pharmaceuticals Holding Corp (TNXP) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 93.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Check out the current performance indicators for Tonix Pharmaceuticals Holding Corp (TNXP). In the past quarter, the stock posted a quick ratio of 11.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 27.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2930.78, a number that is poised to hit -5.18 in the next quarter and is forecasted to reach -6.08 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Analysing the last 5-days average volume posted by the [Tonix Pharmaceuticals Holding Corp, TNXP], we can find that recorded value of 0.82 million was lower than the volume posted last year of 1.36 million. As of the previous 9 days, the stock’s Stochastic %D was 36.13%. Additionally, its Average True Range was 4.05.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 58.61%, which indicates a significant increase from 52.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 106.58% in the past 14 days, which was lower than the 212.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.23, while its 200-day Moving Average is $21.19. Now, the first resistance to watch is $38.84. This is followed by the second major resistance level at $40.72. The third major resistance level sits at $44.46. If the price goes on to break the first support level at $33.22, it is likely to go to the next support level at $29.48. Should the price break the second support level, the third support level stands at $27.60.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
There are currently 7,325K shares outstanding in the company with a market cap of 272.00 million. Presently, the company’s annual sales total 10,090 K according to its annual income of -130,040 K. Last quarter, the company’s sales amounted to 2,430 K and its income totaled -16,830 K.
